API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.law360.com/lifesciences/articles/1513329?utm_source=feedly&utm_medium=rss&utm_campaign=section
https://www.cbsnews.com/news/johnson-and-johnson-families-impacted-by-opioid-epidemic-closely-watching-trial-today-2019-05-28/
https://www.reuters.com/article/us-mallinckrodt-fda/fda-declines-to-approve-mallinckrodts-abuse-deterrent-opioid-painkiller-idUSKBN1OB1BO?feedType=RSS&feedName=healthNews
https://www.raps.org/news-and-articles/news-articles/2018/8/fda-to-replace-analgesic-drug-development-guidance?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2030%20August
https://www.reuters.com/article/us-pain-therapeutic-fda/fda-declines-to-approve-pain-therapeutics-abuse-deterrent-opioid-drug-idUSKBN1KR195
https://www.fiercepharma.com/legal/mallinckrodt-probed-over-oxymorphone-generics-growing-opioid-crisis
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210175
https://www.reuters.com/article/us-endo-intl-subpeona/u-s-subpoenas-endo-for-information-on-opioid-painkillers-idUSKBN1F01T3
http://www.prnewswire.com/news-releases/impax-announces-settlement-of-contract-litigation-on-opana-er-oxymorphone-hydrochloride-cii-extended-release-tablets-300500192.html
http://www.fiercebiotech.com/biotech/news-note-gsk-s-r-d-fix-leo-hitgen-deal-stanford-i-o-pact?utm_source=internal&utm_medium=rss
http://www.fiercepharma.com/marketing/takeda-debuts-final-chapters-ibd-superheroes-comic-book-wraps-first-marvel-co
http://www.raps.org/Regulatory-Focus/News/2017/07/14/28087/Report-Calls-on-FDA-to-Adopt-New-Standard-for-Reviewing-Opioids/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
http://raps.org/Regulatory-Focus/News/2017/07/06/28045/Endo-Pulls-Opioid-From-US-Market-at-FDAs-Request/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
http://www.nbcnews.com/storyline/americas-heroin-epidemic/fda-asks-drug-company-pull-its-opioid-opana-because-abuse-n770121
http://www.nasdaq.com/article/endos-endp-opana-ers-risk-benefit-evaluated-by-fda-cm761979
http://seekingalpha.com/article/4054181-fda-panel-re-examine-opana-er
https://www.bloomberg.com/news/features/2016-12-12/is-kratom-a-deadly-drug-or-a-life-saving-medicine
http://www.fiercepharma.com/pharma/endo-withdraws-bid-to-add-abuse-deterrent-to-opana-s-label
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-us-food-and-drug-administration-nod-for-two-drugs/articleshow/52006823.cms
http://www.biospectrumasia.com/biospectrum/news/223065/kempharm-plans-develop-prodrug-oxymorphone
http://www.prnewswire.com/news-releases/endo-announces-us-district-court-ruling-upholding-opana-er-intellectual-property-300128849.html
http://www.fiercebiotech.com/story/collegium-swings-75m-ipo-its-abuse-proof-painkiller/2015-05-01
https://www.pharmacompass.com/pdf/news/suns-generic-oxymorphone-hcl-approved-in-usa-for-moderate-to-severe-pain-1443365933.pdf